What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK in Q2 2023?

233 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK for Q2 2023. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX)

CUSIP: 09058V103

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / COMMON STOCK
Total 13F shares: 174,092,743
Total 13F value: $1,225,943,210
Share change: +3,616,989
Put/Call ratio: 21%
SEC-reported price per share: $7.04
Number of holders: 233
Value change: +$15,794,543
Number of buys: 124
Number of sells: 84
Shares outstanding: 249,150,204

Security key

09058V103

Report period

Q2 2023

Institutions

233

Top holders

BCRX full security history Ownership snapshot Full 13F holder table BIOCRYST PHARMACEUTICALS INC SEC filings BIOCRYST PHARMACEUTICALS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Mar 2023

13F Lead comparable stake: 6% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 6%

BlackRock Finance, Inc. 6%

BAKER BROS. ADVISORS LP 5.1%

STATE STREET CORP 4.6%

Avoro Capital Advisors LLC 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	6%	$123,649,783 14,826,113 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	6%	$123,638,815 14,824,798 shares	—	31 Mar 2023
BAKER BROS. ADVISORS LP	13F Company 13F	5.1%	$106,008,222 12,710,818 shares	—	31 Mar 2023
STATE STREET CORP	13F Company 13F	4.6%	$94,989,576 11,389,623 shares	—	31 Mar 2023
Avoro Capital Advisors LLC	13F Company 13F	4.2%	$86,902,800 10,420,000 shares	—	31 Mar 2023
PICTET ASSET MANAGEMENT SA	13F Company 13F	2.3%	$46,857,222 5,618,372 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

233

174,092,743

Rows available

233

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

237

Q2 2023 holders

233

Holder diff

-4

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %